This webinar will delve into the offerings of an investigative lab such as EAG Laboratories, which offer services such as medical device testing, extractables and leachables, deformulation/reverse engineering, failure analysis, custom synthesis, materials identification and polymer analysis to clients in many industry sectors. This webinar will showcase three examples of the types of testing offered by EAG Laboratories that aim to address requirements under the new MDR. Their case studies will include characterization of the base polymer of a medical device as well as analytical approaches for identification and quantitation of additives. The featured speakers will also discuss extractables and leachables studies designed to assess the potential for patient exposure using worst-case scenario (extractable) as well as typical exposure conditions (leachable). Finally, the webinar will also describe some possible follow-up steps after the testing is complete and results reported.
Learn about what to expect in terms of the scope of the testing, the analytical approach and turnaround times involved in order to address the new requirements of the MDR, which go into full-force effect in May 2020.
In this webinar we will cover: